WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 32.54
+1.10 (3.50%)
Jan 2, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 129.79 billion as of January 2, 2026. Its market cap has increased by 82.31% in one year.
Market Cap
129.79B
Enterprise Value
126.15B
Revenue
21.98B
Ranking
n/a
PE Ratio
29.03
Stock Price
32.54
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 129.79B, an increase of 305.10%. That is a compound annual growth rate of 17.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 129.79B | 80.01% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.67B |
| Hansoh Pharmaceutical Group Company | 218.43B |
| JD Health International | 178.11B |
| Innovent Biologics | 131.21B |
| Sino Biopharmaceutical | 110.48B |
| Akeso | 104.09B |
| CSPC Pharmaceutical Group | 96.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 91.46B |